CAS: 23290-26-8 - Avenasterol
Formula:C29H48O
InChI:InChI=1S/C29H48O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h7,11,19-20,22-23,25-27,30H,8-10,12-18H2,1-6H3/b21-7-/t20-,22+,23+,25-,26+,27+,28+,29-/m1/s1
InChI key:InChIKey=MCWVPSBQQXUCTB-OQTIOYDCSA-N
SMILES:OC1CCC2(C)C3C(=CCC2C1)C4CCC(C(C)CCC(=CC)C(C)C)C4(C)CC3
- Synonyms:
- (24Z)-24-Ethyl-5a-cholesta-7,24(28)-dien-3b-ol
- (24Z)-5a-Stigmasta-7,24(28)-dien-3b-ol
- (3β,5α,24Z)-Stigmasta-7,24(28)-dien-3-ol
- (Z)-5a-Stigmasta-7,24(28)-dien-3b-ol
- 24Z-Ethylidenelathosterol
- 3b-Hydroxy-5a-stigmasta-7,24(28)Z-diene
- 5a-Stigmasta-7,24(28)-dien-3-ol
- 5a-Stigmasta-7,24(28)-dien-3b-ol, (Z)- (8CI)
- 5a-Stigmasta-7,Z-24(28)-diene-3b-ol
- 5α-Stigmasta-7,24(28)-dien-3β-ol, (Z)-
- See more synonyms
- Avenasterol
- D7-Avenasterol
- Z-24-Ethylidene-5a-cholest-7-en-3b-ol
- Δ<sup>7</sup>-Avenasterol
- Stigmasta-7,24(28)-dien-3-ol, (3β,5α,24Z)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Stigmasta-7,24(28)-dien-3-ol, (3β,5α,24Z)- REF: IN-DA002MSCCAS: 23290-26-8 | - - - | To inquire | Thu 02 Jan 25 | |
δ-7-Avenasterol REF: 4Z-A-167001CAS: 23290-26-8 | - - - | To inquire | Tue 07 Jan 25 | |
δ7-Avenasterol (E/Z mixture) REF: TR-A794825CAS: 23290-26-8 | - - - | 379.00 €~2,553.00 € | Fri 10 Jan 25 | |
δ7-Avenasterol-d4 REF: TR-A794827CAS: 23290-26-8 | - - - | 17,795.00 € | Mon 10 Feb 25 | |
δ 7-avenasterol REF: 3D-FA165752CAS: 23290-26-8 | Min. 95% | - - - | Discontinued product |
Stigmasta-7,24(28)-dien-3-ol, (3β,5α,24Z)-
Ref: IN-DA002MSC
5mg | To inquire |
Ref: 4Z-A-167001
10mg | 2,645.00 € | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
δ7-Avenasterol (E/Z mixture)
Ref: TR-A794825
5mg | 2,553.00 € | ||
500µg | 379.00 € |
δ7-Avenasterol-d4
Controlled ProductRef: TR-A794827
75mg | 17,795.00 € |
δ 7-avenasterol
Controlled ProductRef: 3D-FA165752
1mg | Discontinued | Request information | |
250µg | Discontinued | Request information | |
500µg | Discontinued | Request information |